Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives

Transfusion and Apheresis Science

Volumn 43, Issue 2, 2010, Pages 227-229

  Vernia, Piero ^a   D'Ovidio, Valeria ^a   Meo, Donatella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Granulocyte monocyte apheresis; Inflammatory bowel disease; Leukocytapheresis; Steroid dependency

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADSORPTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILL; CLINICAL PROTOCOL; CYTAPHERESIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERITIS; FEVER; GRANULOCYTE; HEADACHE; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MONOCYTE; NAUSEA; PATIENT SAFETY; REMISSION; STEROID THERAPY; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; BLOOD COMPONENT REMOVAL; CHEMOKINES; CHILD; CLINICAL TRIALS AS TOPIC; COLITIS, ULCERATIVE; CROHN DISEASE; GRANULOCYTES; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKAPHERESIS; MACROPHAGES; MONOCYTES; STEROIDS; TIME FACTORS;

EID: 77958152672     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2010.07.023     Document Type: Article

References (21)

1. Kornbluth A., Marion J.F., Salomon P., Janowitz H.D. How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials. J Clin Gastroenterol 1995, 20:280-284.
2. Sakata Y., Iwakiri R., Amemori S., Yamaguchi K., Fujise T., Otani H., et al. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study. Eur J Gastroenterol Hepatol 2008, 20:629-633.
3. Sandborn W.J. Preliminary data on the use of the apheresis in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12(Suppl. 1):15-21.
4. Hanai H. Position of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006, 47:7568-7577.
5. Caprilli R., D'Ovidio V. Leukocytapheresis as promising therapy for inflammatory bowel disease. Digest Liver Dis 2007, 39:435-437.
6. Suzuki Y., Yoshimura N., Saniabadi A.R., Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naïve patients with ulcerative colitis: a prospective uncontrolled study. Digest Dis Sci 2004, 49:565-571.
7. Sakuraba A., Motoya S., Watanabe K., Nishishita M., Kanke K., Matsui T., et al. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment. Am J Gastroenterol 2009, 104:2990-2995.
8. Dignass A. Granulocyte-monocyte adsorptive (GMA) apheresis in UC: is the treatment efficacy dose-dependent? Results of a randomized comparison of 5 vs 10. The CESA 5.10 study. Aliment Pharmacol Ther, in press.
9. Hebermalz B, Sauerland S. Clinical effectiveness of selective granulocyte, monocyte adsorptive apheresis with the Adacolumn device in ulcerative colitis. Digest Dis Sci; 2009 [Epub ahead of print].
10. Domènech E., Hinojosa J., Esteve-Comas M., Gomollón F., Herrera J.M., Bastida G., et al. Granulocytaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study (GETECCU). Aliment Pharmacol Ther 2004, 20:1347-1352.
11. Tanaka T., Okanobu H., Yoshimi S., Murakami E., Kogame A., Imagawa H., et al. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients. Digest Liver Dis 2008, 40:731-736.
12. Saniabadi A.R., Hanai H., Suzuki Y., Ohmori T., Sawada K., Yoshimura N., et al. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjuvant or an alternative to drug therapy?. J Clin Apher 2005, 20:171-184.
13. Bresci G., Parisi G., Mazzoni A., Scatena F., Capria A. Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study. Digest Liver Dis 2007, 39:430-434.
14. Shimoyama T., Sawada K., Hiwatashi N., Sawada T., Matsueda K., Munakata A., et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001, 16:1-9.
15. Shimada M., Iwase H., Tsuzuki T., Hirashima N., Kobayashi K., Hibino Y., et al. A pilot study of leukocytapheresis efficacy with 1.5liter blood processing volume in patients with ulcerative colitis. Ther Apher Dial 2008, 12:368-373.
16. Mitsuyama K., Sata M. Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action. Cytotherapy 2009, 11:229-237.
17. Hibi T., Ameshima Y., Sekiguchi Y., Hisatome Y., Maruyama F., Moriwaki K., et al. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. Digest Liver Dis 2009, 41:570-577.
18. Matsumoto T., Andoh A., Okawa K., Ito H., Torii A., Yoshikawa S., et al. Multivariate analysis for factors predicting rapid response of leukocytapheresis in patient with steroid-resistant ulcerative colitis: a multicenter prospective open-label study. Ther Apher Dial 2008, 12:484-490.
19. Sawada K., Kusugami K., Suzuki Y., Bamba T., Munakata A., Hibi T., et al. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am J Gastroenterol 2005, 100:1362-1369.
20. Sands B., Sandborn W.J., Feagan B., Lofberg R., Hibi T., Wang T., et al. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Gastroenterology 2008, 135:400-409.
21. Ruuska T., Wewer V., Lindgren F., Malmborg P., Lindquist M., Marthinsen L., et al. Granulocyte-monocyte apheresis in pediatric inflammatory bowel disease: results, practical issues, safety and future perspectives. Inflamm Bowel Dis 2009, 15:1049-1054.